Model No.: 1.4%
This medication is recommended for:• Metabolic acidosis (high blood acidity);
• Poisoning by phenobarbital.
If you are a distributor, please inquire with us about product registration, importing and/or marketing our products in your country or region.
If you are a consumer, don't hesitate to contact us about more information for this product.
NOUVASANT GROUP LTD.
NOUVASANT is headquartered in Nanjing city, located in the lower reaches of the Yangtze River, one of the six ancient capitals of China. NOUVASANT is composed of research, development, production and sales. All the production workshops have passed the national GMP certification, and the production process is in strict accordance with the GMP requirements.
Products cover: antipyretic analgesic, antibiotic series, respiratory drugs, nervous system drugs, cardiovascular drugs, digestive system drugs, anti-malarial drugs, anti-cancer drugs, covering pharmaceutical API and Preparations.
Core Value: In Search of Excellence
Mission: devoted to providing safe, effective, high-quality and humanized products to Humankind.
- Company Name: NOUVASANT GROUP LTD.
- Product/Service: Finished Pharmaceutical Product , API & Raw materials , Antimalarial , Antibiotic & Antimicrobial , Medical Disposables , Antifungal Drugs
- Capital (Million US $): 21,000,000RMB
- Year Established: 2010
- Total Annual Sales Volume (Million US $): US$10 Million - US$50 Million
- Export Percentage: 71% - 80%
- Total Annual Purchase Volume (Million US $): US$10 Million - US$50 Million
- No. of Production Lines: Above 20
- No. of R&D Staff: 21 -30 People
- No. of QC Staff: 11 -20 People
- OEM Services Provided: yes
- Factory Size (Sq.meters): 30,000-50,000 square meters
- Factory Location: No.1 North Zhongshan Road, Gulou, Nanjing, 210009, China
- Contact Person: Mr. Andy
- Tel: 86-025-58771602
Premium Related Products